Home › NDC Lookup › RxCUI directory › RxCUI 1806948

Doxycycline hyclate 50 MG Oral Tablet [Targadox] — RxCUI 1806948

RxNorm drug concept · Semantic branded drug
RxCUI 1806948 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1806948
Official nameDoxycycline hyclate 50 MG Oral Tablet [Targadox]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTargadox 50 MG Oral Tablet
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Doxycycline Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The IV form is used when you're not able to swallow or absorb oral medication — for example, if you're too sick, vomiting, or need a faster, more reliable delivery of the antibioti...
  • Why am I getting doxycycline through an IV instead of just taking a pill?
  • It depends on what infection you're being treated for. For most infections, treatment continues for at least 24 to 48 hours after your fever and symptoms have cleared. For somethin...
  • How long will I need to be on this antibiotic?
📖 Read our full Doxycycline Injection guide →

🕸️ Concept Web — How Doxycycline hyclate 50 MG Oral Tablet [Targadox] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Doxycycline hyclate 50 MG Oral Tablet [Targadox] RxCUI 1806948

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Doxycycline 3640
    • Doxycycline hyclate 23663
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Targadox 1806943
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Doxycycline Oral Tablet 371966
    • Doxycycline hyclate Oral Tablet 2648109
    • Doxycycline Oral Product 1160778
    • Doxycycline Pill 1160779
    • Doxycycline hyclate Oral Product 2663263
    • Doxycycline hyclate Pill 2661949
    • Doxycycline Oral Tablet [Targadox] 1806945
    • Doxycycline hyclate Oral Tablet [Targadox] 2656000
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Doxycycline hyclate 50 MG Oral Tablet SCD · 1652674
  • Doxycycline hyclate 50 MG SCDC · 1649404
  • Doxycycline Oral Tablet SCDF · 371966
  • Doxycycline hyclate Oral Tablet SCDFP · 2648109
  • Doxycycline Oral Product SCDG · 1160778
  • Doxycycline Pill SCDG · 1160779
  • Doxycycline hyclate Oral Product SCDGP · 2663263
  • Doxycycline hyclate Pill SCDGP · 2661949

Brand-Name Concepts

  • Doxycycline hyclate 50 MG [Targadox] SBDC · 1806944
  • Doxycycline Oral Tablet [Targadox] SBDF · 1806945
  • Doxycycline hyclate Oral Tablet [Targadox] SBDFP · 2656000
  • Targadox Oral Product SBDG · 1806946
  • Targadox Pill SBDG · 1806947
  • Targadox BN · 1806943

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1806948 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
69489-0111-05 5 TABLET in 1 BOTTLE (69489-111-05) TARGADOX Journey Medical Corporation 2016-08-29
69489-0111-60 60 TABLET in 1 BOTTLE (69489-111-60) TARGADOX Journey Medical Corporation 2016-08-29
Observed labelers: Journey Medical Corporation (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.